Skip to content
Screener

CareDx CDNA Q3 2025 earnings

Reported November 4, 2025 · After market close

Revenue$100.1MMiss by $2.7M
EPS$0.28Beat by $0.15
Revenue estimate$102.8M
EPS estimate$0.13

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$121.9M
EPS estimate$0.24

Financials

Q3 2025

Income statement

See full
Revenue$100.1M+20.7%
Operating income-$246.0K+98.2%
Net income$1.7M+116%
EPS (diluted)$0.03+115%

Balance sheet

See full
Cash & equivalents$92.0M-4.2%
Total debt$27.6M-7.7%
Total equity$311.1M+13.9%
Total assets$432.3M-9.4%

Cash flow

See full
Operating cash flow$37.4M+198%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$773.92M-53.0%
Enterprise value$709.58M-55.1%
P/E11×—
P/S2.2×-3.1×

Profitability

See full
Operating margin16.7%+9.5pp
Net margin19.7%+11.5pp

Returns & leverage

See full
Return on equity24.1%+14.6pp
Debt / equity0.1×0.0×
Current ratio3×-1.1×

Segments

By product

See full
Testing services revenue$72.2M—
Patient and digital solutions revenue$15.4M—

By segment

See full
Reportable Segment$100.1M+20.7%

FAQ

When did CareDx report Q3 2025 earnings?
CareDx (CDNA) reported Q3 2025 earnings on November 4, 2025 after market close.
What were CareDx's Q3 2025 revenue and EPS?
CareDx reported revenue of $100.1M and eps of $0.28 for Q3 2025.
Did CareDx beat estimates in Q3 2025?
Revenue missed the consensus estimate of $102.8M by $2.7M. EPS beat the consensus estimate of $0.13 by $0.15.
How did CareDx's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 20.7% from $82.9M a year earlier and eps grew 100.0% from $0.14.
Where can I find CareDx's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001217234-25-000062) and the 10-Q periodic report (0001217234-25-000063) directly on SEC EDGAR. The filing index links above go to sec.gov.